Create account

Coverage dated September 21, 2026 to September 25, 2026

Patients claim popular GLP-1 drugs led to permanent vision loss

Headline from News Nation Now, from the development of Sep 21, 2026

Newest development Sep 23, 2026 · 2 reportsLawsuits claim popular GLP-1 drugs linked to vision loss

“The risk-benefit of these drugs are still really, really good,” Rutgers Associate Professor Chintan Dave said.

News Nation Now's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Developments in this update

2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.

  1. Names this update

    Patients claim popular GLP-1 drugs led to permanent vision loss

    Headline from News Nation Now ·

  2. Newest

    Lawsuits claim popular GLP-1 drugs linked to vision loss

    Headline from Arklatex Home Page ·

33 reports not tied to one development ·

Read the reports

Reports & sources

50 articles, oldest first.

  1. News Nation Now

    Patients sue GLP-1 makers over sudden loss of vision (opens News Nation Now)

    Published

    News Nation Now's feed description

    Patients say the pharmaceutical companies failed to warn them of a risk of a rare condition that causes vision loss.

  2. ABC 13 Houston

    Wegovy, Mounjaro, Ozempic and vision loss: and What users should know about GLP-1 side effects, potential risk of NAION (opens ABC 13 Houston)

    Published

    ABC 13 Houston's feed description

    Dozens of lawsuits against the makers of drugs like Ozempic, Wegovy, and Mounjaro surround claims of GLP 1 vision loss cases.

  3. The Boston Globe

    Could GLP-1s be linked to a rare type of vision loss? Here’s what to know. (opens The Boston Globe)

    Published

    The Boston Globe's feed description

    In recent months, dozens of people have sued makers of widely used GLP-1s, claiming that the medication caused sudden and often permanent blindness.

  4. WHDH Boston

    Lawsuits filed against GLP-1 makers over reported vision damage (opens WHDH Boston)

    Published

    WHDH Boston's feed description

    Thousands of lawsuits have been filed against the makers of GLP-1 drugs as more people report vision loss while taking them. Patients claim the popular...

  5. FOX8 WGHP

    Patients sue GLP-1 drug makers over vision loss risk (opens FOX8 WGHP)

    Published

    FOX8 WGHP's feed description

    Patients say the pharmaceutical companies failed to warn them of a risk of a rare condition that causes vision loss.

  6. Townhall

    Patients Are Suing GLP-1 Manufacturers Alleging Weight-Loss Drugs Cause Rare Type of Vision Loss (opens Townhall)

    Published

  7. Al Jazeera

    Dozens of people sue GLP-1 drug companies over alleged vision loss (opens Al Jazeera)

    Published

    Al Jazeera's feed description

    More than 90 lawsuits against GLP-1 companies claim rare eye condition resulted from diabetes and weight loss drugs.

  8. Fox News

    Popular weight-loss drugs face numerous lawsuits over rare ‘eye stroke’ linked to vision loss (opens Fox News)

    Published

    Fox News's feed description

    Hundreds of consumers allege GLP-1 drugs like Ozempic and Wegovy caused NAION, a rare eye stroke linked to sudden, often permanent vision loss.

  9. News Nation Now

    Patients claim popular GLP-1 drugs led to permanent vision loss (opens News Nation Now)

    Published

    News Nation Now's feed description

    “The risk-benefit of these drugs are still really, really good,” Rutgers Associate Professor Chintan Dave said.

  10. NBC Los Angeles

    Woman details losing vision in 1 eye after taking GLP-1 as hundreds of patients sue drug companies (opens NBC Los Angeles)

    Published

    NBC Los Angeles's feed description

    Diane Wirth’s life has been upended since losing her vision, which she believes was due to taking Wegovy.

  11. PhillyVoice

    GLP-1 drugmakers are being sued by patients who suddenly lost their vision (opens PhillyVoice)

    Published

    PhillyVoice's feed description

    Novo Nordisk and Eli Lilly are being sued by patients who say their GLP-1 weight-loss drugs have caused sudden vision loss. The lawsuits claim the patients should have been warned that vision loss was a rare side effect. The pharmaceutical companies say the lawsuits have no merit.

  12. Arklatex Home Page

    Lawsuits claim popular GLP-1 drugs linked to vision loss (opens Arklatex Home Page)

    Published

    Arklatex Home Page's feed description

    Patients filed lawsuits against manufacturers of GLP-1 medications, including Ozempic and Wegovy, alleging the drugs caused non-arteritic anterior ischemic optic neuropathy and permanent vision loss.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Related updates

Separate coverage close to this update in time and subject.

Patients claim popular GLP-1 drugs led to permanent vision loss | Since Then